Chemoinformaics analysis of 2-Methyl-oct-2-enedial
Molecular Weight | 154.209 | nRot | 6 |
Heavy Atom Molecular Weight | 140.097 | nRig | 3 |
Exact Molecular Weight | 154.099 | nRing | 0 |
Solubility: LogS | -1.399 | nHRing | 0 |
Solubility: LogP | 0.647 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 25.9691 |
nHD | 0 | BPOL | 15.7809 |
QED | 0.332 |
Synth | 2.978 |
Natural Product Likeliness | 2.597 |
NR-PPAR-gamma | 0.062 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.028 |
Pgp-sub | 0.002 |
HIA | 0.011 |
CACO-2 | -4.524 |
MDCK | 0.0000221 |
BBB | 0.992 |
PPB | 0.379257 |
VDSS | 0.986 |
FU | 0.696824 |
CYP1A2-inh | 0.17 |
CYP1A2-sub | 0.758 |
CYP2c19-inh | 0.091 |
CYP2c19-sub | 0.572 |
CYP2c9-inh | 0.023 |
CYP2c9-sub | 0.932 |
CYP2d6-inh | 0.016 |
CYP2d6-sub | 0.739 |
CYP3a4-inh | 0.023 |
CYP3a4-sub | 0.152 |
CL | 5.73 |
T12 | 0.83 |
hERG | 0.011 |
Ames | 0.941 |
ROA | 0.025 |
SkinSen | 0.965 |
Carcinogencity | 0.049 |
EI | 0.993 |
Respiratory | 0.973 |
NR-Aromatase | 0.079 |
Antiviral | No |
Prediction | 0.952581 |